Neuro-Bio welcomes Anna Ashton as senior postdoc scientist. Anna has over ten years’ experience in research spanning pharmaceutical, biotech and academic labs. She graduated with a PhD in Medical Sciences from the University of Aberdeen, in which she studied the role of retinoic acid in the pineal gland. She then gained postdoctoral experience in the Clinical Neurosciences department at the University of Oxford, where she studied the molecular mechanisms of the circadian clock through genomic, proteomic and imaging approaches.
LATEST NEWS
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!